Sarasin & Partners’s Xylem XYL Stock Holding History

Sarasin & Partners’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-12,201	Closed	-$545K	–	140
2016 Q2	$545K	Sell	12,201 -9,299	-43%	-$404K	0.01%	133
2016 Q1	$879K	Buy	21,500 +6,600	+44%	+$243K	0.01%	121
2015 Q4	$544K	Hold	14,900	–	–	0.01%	127
2015 Q3	$489K	Sell	14,900 -15,000	-50%	-$505K	0.01%	124
2015 Q2	$1.11M	Buy	+29,900	New	+$1.09M	0.02%	125

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Sarasin & Partners's XYL Position: Q3 2016 in Review

Sarasin & Partners sold out of Xylem (XYL) in Q3 2016, closing a stake of 12,201 shares — an estimated $545K sold.

Sarasin & Partners first reported a position in XYL in Q2 2015 and held it in 5 quarters. The position peaked at $1.11M in Q2 2015. 521 funds tracked by Wall St. Rank hold XYL as of Q3 2016.

Sarasin & Partners reported no remaining Xylem position as of Q3 2016 after selling out during the quarter.
Sarasin & Partners sold 12,201 Xylem shares in Q3 2016, an estimated $545K.
Sarasin & Partners first reported a position in Xylem in Q2 2015 and held it in 5 quarters.
Sarasin & Partners's Xylem position peaked at $1.11M in Q2 2015.
521 funds tracked by Wall St. Rank held Xylem as of Q3 2016.

Based on Sarasin & Partners's 13F filing for Q3 2016, filed 14 Oct 2016.